115 related articles for article (PubMed ID: 11021736)
1. Ara-C differentially affects multiprotein forms of human cell DNA polymerase.
Wills PW; Hickey R; Malkas L
Cancer Chemother Pharmacol; 2000; 46(3):193-203. PubMed ID: 11021736
[TBL] [Abstract][Full Text] [Related]
2. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
[TBL] [Abstract][Full Text] [Related]
3. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
Abdel-Aziz W; Hickey RJ; Malkas LH
Biochem Pharmacol; 2004 Jul; 68(1):11-21. PubMed ID: 15183113
[TBL] [Abstract][Full Text] [Related]
4. A novel in vitro model system for studying the action of ara-C.
Wills P; Hickey R; Ross D; Cuddy D; Malkas L
Cancer Chemother Pharmacol; 1996; 38(4):366-72. PubMed ID: 8674160
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP).
Han S; Hickey RJ; Tom TD; Wills PW; Syväoja JE; Malkas LH
Biochem Pharmacol; 2000 Aug; 60(3):403-11. PubMed ID: 10856436
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
Townsend AJ; Cheng YC
Mol Pharmacol; 1987 Sep; 32(3):330-9. PubMed ID: 2444869
[TBL] [Abstract][Full Text] [Related]
7. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.
Gandhi V; Estey E; Keating MJ; Chucrallah A; Plunkett W
Blood; 1996 Jan; 87(1):256-64. PubMed ID: 8547650
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.
Ohno Y; Spriggs D; Matsukage A; Ohno T; Kufe D
Cancer Res; 1988 Mar; 48(6):1494-8. PubMed ID: 3345522
[TBL] [Abstract][Full Text] [Related]
9. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
10. Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.
Coll JM; Hickey RJ; Cronkey EA; Jiang HY; Schnaper L; Lee MY; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1997; 9(11-12):629-39. PubMed ID: 9563011
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.
Gandhi V; Huang P; Chapman AJ; Chen F; Plunkett W
Clin Cancer Res; 1997 Aug; 3(8):1347-55. PubMed ID: 9815818
[TBL] [Abstract][Full Text] [Related]
12. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
[TBL] [Abstract][Full Text] [Related]
13. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
Seymour JF; Huang P; Plunkett W; Gandhi V
Clin Cancer Res; 1996 Apr; 2(4):653-8. PubMed ID: 9816215
[TBL] [Abstract][Full Text] [Related]
14. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
Abe I; Saito S; Hori K; Suzuki M; Sato H
Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
16. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
[TBL] [Abstract][Full Text] [Related]
17. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
Grant S; Turner A; Nelms P; Yanovich S
Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a DNA synthesome from a neuroblastoma cell line.
Sandoval JA; Hickey RJ; Malkas LH
J Pediatr Surg; 2005 Jul; 40(7):1070-7. PubMed ID: 16034747
[TBL] [Abstract][Full Text] [Related]
20. The human breast cell DNA synthesome: its purification from tumor tissue and cell culture.
Coll JM; Sekowski JW; Hickey RJ; Schnaper L; Yue W; Brodie AM; Uitto L; Syvaoja JE; Malkas LH
Oncol Res; 1996; 8(10-11):435-47. PubMed ID: 9114436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
